Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KALBITOR® safely and effectively. See full prescribing information for KALBITOR. KALBITOR (ecallantide) injection, for subcutaneous use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
- generic_name
- ecallantide
- product_names
- Ecallantide
- ndc
- 47783-101, 47783-101-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en